サマリー

市場の分析と洞察。アジア太平洋地域の薬物乱用検査機器市場
アジア太平洋地域の薬物乱用検査機器市場は、2022年に1億9,488万米ドルの市場規模を記録しています。市場規模は2028年末までに3億1677万米ドルに達し、2022年から2028年の間に8.43%のCAGRで成長すると予測されます。
アジア太平洋地域の薬物乱用検査装置の範囲とセグメント
乱用薬物検査機器市場は、タイプ別、用途別に分類されています。アジア太平洋地域の薬物検査装置市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができます。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。
企業別
アボット社
サーモフィッシャー
ロシュ
シーメンス・ヘルスマインダ
ウォンドフォ・バイオテック
ランドックス
オラシュア
ドレーゲル
インテック
オリエントジーン
杭州ビオテスト
アシュアテック
アオタイバイオ

種類別セグメント
尿検査
唾液検査
血液検査
毛髪・汗の検査
その他

用途別セグメント
病院
法執行機関
薬物治療センター
研究室
その他

地域・国別セグメント
中国
日本
韓国
インド
中国 台湾
オーストラリア
インドネシア
タイ
マレーシア
フィリピン
ベトナム
シンガポール
その他の地域

ページTOPに戻る

目次

1 STUDY COVERAGE 1
1.1 Drugs of Abuse Testing Devices Product Introduction 1
1.2 Market by Type 1
1.2.1 Asia-Pacific Drugs of Abuse Testing Devices Market Size Growth Rate by Type 1
1.2.2 Urine Testing 2
1.2.3 Saliva Testing 3
1.2.4 Blood Testing 4
1.2.5 Hair and Sweat Testing 5
1.2.6 Others 6
1.3 Market by Application 7
1.3.1 Asia-Pacific Drugs of Abuse Testing Devices Market Size Growth Rate by Application 7
1.3.2 Hospital 8
1.3.3 Law Enforcement 9
1.3.4 Drug Treatment Center 10
1.3.5 Laboratory 10
1.3.6 Others 11
1.4 Study Objectives 11
1.5 Years Considered 12
2 EXECUTIVE SUMMARY 13
2.1 Asia-Pacific Drugs of Abuse Testing Devices Sales Estimates and Forecasts 2017-2028 13
2.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue Estimates and Forecasts 2017-2028 14
2.3 Asia-Pacific Drugs of Abuse Testing Devices Revenue by Region: 2017 VS 2022 VS 2028 15
2.4 Asia-Pacific Top Drugs of Abuse Testing Devices Regions by Sales 16
2.4.1 Asia-Pacific Top Drugs of Abuse Testing Devices Regions by Sales (2017-2022) 16
2.4.2 Asia-Pacific Top Drugs of Abuse Testing Devices Regions by Sales (2023-2028) 17
2.5 Asia-Pacific Top Drugs of Abuse Testing Devices Regions by Revenue 19
2.5.1 Asia-Pacific Top Drugs of Abuse Testing Devices Regions by Revenue (2017-2022) 19
2.5.2 Asia-Pacific Top Drugs of Abuse Testing Devices Regions by Revenue (2023-2028) 20
2.6 China 21
2.7 Japan 22
2.8 South Korea 23
2.9 India 24
2.10 China Taiwan 25
2.11 Australia 26
2.12 Indonesia 27
2.13 Thailand 28
2.14 Malaysia 29
2.15 Philippines 30
2.16 Vietnam 31
2.17 Singapore 32
3 COMPETITION BY MANUFACTURERS 33
3.1 Asia-Pacific Drugs of Abuse Testing Devices Sales by Manufacturers 33
3.1.1 Asia-Pacific Top Drugs of Abuse Testing Devices Manufacturers by Sales (2017-2022) 33
3.1.2 Asia-Pacific Top Drugs of Abuse Testing Devices Manufacturers Market Share by Sales (2017-2022) 34
3.1.3 Asia-Pacific Key Companies Sales Share in 2021 35
3.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue by Manufacturers 35
3.2.1 Asia-Pacific Top Drugs of Abuse Testing Devices Manufacturers by Revenue (2017-2022) 35
3.2.2 Asia-Pacific Top Drugs of Abuse Testing Devices Manufacturers Market Share by Revenue (2017-2022) 36
3.2.3 Asia-Pacific Top 10 and Top 5 Companies by Drugs of Abuse Testing Devices Revenue in 2021 37
3.3 Asia-Pacific Drugs of Abuse Testing Devices Sales Price by Manufacturers 38
3.4 Analysis of Competitive Landscape 38
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 38
3.4.2 Asia-Pacific Drugs of Abuse Testing Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 39
3.4.3 Asia-Pacific Drugs of Abuse Testing Devices Manufacturers Geographical Distribution 41
3.5 Mergers & Acquisitions, Expansion Plans 42
4 MARKET SIZE BY TYPE 44
4.1 Asia-Pacific Drugs of Abuse Testing Devices Sales by Type 44
4.1.1 Asia-Pacific Drugs of Abuse Testing Devices Historical Sales by Type (2017-2022) 44
4.1.2 Asia-Pacific Drugs of Abuse Testing Devices Forecasted Sales by Type (2023-2028) 44
4.1.3 Asia-Pacific Drugs of Abuse Testing Devices Sales Market Share by Type (2017-2028) 45
4.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue by Type 46
4.2.1 Asia-Pacific Drugs of Abuse Testing Devices Historical Revenue by Type (2017-2022) 46
4.2.2 Asia-Pacific Drugs of Abuse Testing Devices Forecasted Revenue by Type (2023-2028) 46
4.2.3 Asia-Pacific Drugs of Abuse Testing Devices Revenue Market Share by Type (2017-2028) 46
4.3 Asia-Pacific Drugs of Abuse Testing Devices Price by Type 48
4.3.1 Asia-Pacific Drugs of Abuse Testing Devices Price by Type (2017-2022) 48
4.3.2 Asia-Pacific Drugs of Abuse Testing Devices Price Forecast by Type (2023-2028) 48
5 MARKET SIZE BY APPLICATION 49
5.1 Asia-Pacific Drugs of Abuse Testing Devices Sales by Application 49
5.1.1 Asia-Pacific Drugs of Abuse Testing Devices Historical Sales by Application (2017-2022) 49
5.1.2 Asia-Pacific Drugs of Abuse Testing Devices Forecasted Sales by Application (2023-2028) 49
5.1.3 Asia-Pacific Drugs of Abuse Testing Devices Sales Market Share by Application (2017-2028) 50
5.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue by Application 51
5.2.1 Asia-Pacific Drugs of Abuse Testing Devices Historical Revenue by Application (2017-2022) 51
5.2.2 Asia-Pacific Drugs of Abuse Testing Devices Forecasted Revenue by Application (2023-2028) 51
5.2.3 Asia-Pacific Drugs of Abuse Testing Devices Revenue Market Share by Application (2017-2028) 52
5.3 Asia-Pacific Drugs of Abuse Testing Devices Price by Application 53
5.3.1 Asia-Pacific Drugs of Abuse Testing Devices Price by Application (2017-2022) 53
5.3.2 Asia-Pacific Drugs of Abuse Testing Devices Price Forecast by Application (2023-2028) 53
6 CORPORATE PROFILE 54
6.1 Abbott 54
6.1.1 Abbott Corporation Information 54
6.1.2 Abbott Overview 54
6.1.3 Abbott in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 55
6.1.4 Abbott Drugs of Abuse Testing Devices Product Description 55
6.1.5 Abbott Recent Developments 57
6.2 Thermo Fisher Scientific 57
6.2.1 Thermo Fisher Scientific Corporation Information 57
6.2.2 Thermo Fisher Scientific Overview 57
6.2.3 Thermo Fisher Scientific in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 58
6.2.4 Thermo Fisher Scientific Drugs of Abuse Testing Devices Product Description 58
6.2.5 Thermo Fisher Scientific Recent Developments 59
6.3 Roche 59
6.3.1 Roche Corporation Information 59
6.3.2 Roche Overview 60
6.3.3 Roche in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 60
6.3.4 Roche Drugs of Abuse Testing Devices Product Description 60
6.3.5 Roche Recent Developments 61
6.4 Siemens Healthineers 62
6.4.1 Siemens Healthineers Corporation Information 62
6.4.2 Siemens Healthineers Overview 62
6.4.3 Siemens Healthineers in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 63
6.4.4 Siemens Healthineers Drugs of Abuse Testing Devices Product Description 63
6.4.5 Siemens Healthineers Recent Developments 64
6.5 Wondfo Biotech 64
6.5.1 Wondfo Biotech Corporation Information 64
6.5.2 Wondfo Biotech Overview 65
6.5.3 Wondfo Biotech in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 65
6.5.4 Wondfo Biotech Drugs of Abuse Testing Devices Product Description 65
6.5.5 Wondfo Biotech Recent Developments 67
6.6 Randox Laboratories 67
6.6.1 Randox Laboratories Corporation Information 67
6.6.2 Randox Laboratories Overview 67
6.6.3 Randox Laboratories in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 68
6.6.4 Randox Laboratories Drugs of Abuse Testing Devices Product Description 68
6.6.5 Randox Laboratories Recent Developments 69
6.7 OraSure 69
6.7.1 OraSure Corporation Information 69
6.7.2 OraSure Overview 69
6.7.3 OraSure in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 70
6.7.4 OraSure Drugs of Abuse Testing Devices Product Description 70
6.7.5 OraSure Recent Developments 71
6.8 Drager 71
6.8.1 Drager Corporation Information 71
6.8.2 Drager Overview 72
6.8.3 Drager in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 72
6.8.4 Drager Drugs of Abuse Testing Devices Product Description 72
6.8.5 Drager Recent Developments 74
6.9 Intec 74
6.9.1 Intec Corporation Information 74
6.9.2 Intec Overview 74
6.9.3 Intec in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 75
6.9.4 Intec Drugs of Abuse Testing Devices Product Description 75
6.9.5 Intec Recent Developments 76
6.10 Orient Gene Biotech 76
6.10.1 Orient Gene Biotech Corporation Information 76
6.10.2 Orient Gene Biotech Overview 76
6.10.3 Orient Gene Biotech in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 77
6.10.4 Orient Gene Biotech Drugs of Abuse Testing Devices Product Description 77
6.10.5 Orient Gene Biotech Recent Developments 78
6.11 Hangzhou Biotest 78
6.11.1 Hangzhou Biotest Corporation Information 78
6.11.2 Hangzhou Biotest Overview 78
6.11.3 Hangzhou Biotest in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 79
6.11.4 Hangzhou Biotest Drugs of Abuse Testing Devices Product Description 79
6.11.5 Hangzhou Biotest Recent Developments 80
6.12 Assure Tech (Hangzhou) Co 80
6.12.1 Assure Tech (Hangzhou) Co Corporation Information 80
6.12.2 Assure Tech (Hangzhou) Co Overview 81
6.12.3 Assure Tech (Hangzhou) Co in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 81
6.12.4 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Devices Product Description 82
6.12.5 Assure Tech (Hangzhou) Co Recent Developments 82
6.13 Aotai Bio 82
6.13.1 Aotai Bio Corporation Information 82
6.13.2 Aotai Bio Overview 83
6.13.3 Aotai Bio in Asia-Pacific: Drugs of Abuse Testing Devices Sales, Price, Revenue and Gross Margin (2017-2022) 83
6.13.4 Aotai Bio Drugs of Abuse Testing Devices Product Description 84
6.13.5 Aotai Bio Recent Developments 85
7 VALUE CHAIN AND SALES CHANNELS ANALYSIS 86
7.1 Drugs of Abuse Testing Devices Value Chain Analysis 86
7.2 Drugs of Abuse Testing Devices Key Raw Materials 87
7.2.1 Key Raw Materials 87
7.2.2 Raw Materials Key Suppliers 87
7.3 Proportion of Manufacturing Cost Structure 88
7.4 Drugs of Abuse Testing Devices Sales and Marketing 88
7.4.1 Drugs of Abuse Testing Devices Sales Channels 88
7.4.2 Drugs of Abuse Testing Devices Distributors 89
7.5 Drugs of Abuse Testing Devices Customers 90
8 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 92
8.1 Drugs of Abuse Testing Devices Industry Trends 92
8.2 Drugs of Abuse Testing Devices Market Drivers 93
8.3 Drugs of Abuse Testing Devices Market Challenges 94
8.4 Drugs of Abuse Testing Devices Market Restraints 94
9 KEY FINDINGS IN THE ASIA-PACIFIC DRUGS OF ABUSE TESTING DEVICES STUDY 96
10 APPENDIX 98
10.1 Research Methodology 98
10.1.1 Methodology/Research Approach 98
10.1.2 Data Source 101
10.2 Author Details 103
10.3 Disclaimer 104